AiON

Does the Seguridad Social cover testosterone? What Spain's public health system pays for and what it doesn't

Spain's public health system can fund testosterone when hypogonadism has been diagnosed within the system and the product prescribed is included in public funding. We explain why not every product has had the same cover, what happened with Reandron, how to check the status of each one and what changes if you are treated privately or by telemedicine.

Medically reviewed byClínica Evolution medical teamPublishedUpdated
¿La Seguridad Social cubre la testosterona? Qué paga la sanidad pública en España y qué no

Short answer

In Spain, the Seguridad Social can fund testosterone when it is prescribed by a doctor in the public system after a diagnosis of hypogonadism, and the product is included in SNS funding. Not every product has had the same cover: without funding, the patient's cost for Reandron went from €4.29 to €128. With a private or telemedicine prescription, you pay the full price of the medicine.

Key points

  1. According to eldiario.es, Reandron went back on sale without public funding at €128, compared with the €4.29 patients paid while it was funded, after the Ministry of Health demanded a 35% price cut.
  2. The Endocrine Society's 2018 guideline requires compatible symptoms and a clearly and repeatedly low testosterone level on blood tests for a diagnosis of hypogonadism.
  3. In the European EMAS study, only 2.1% of 3,369 men aged 40 to 79 met the criteria for late-onset hypogonadism.
  4. In the TRAVERSE trial of 5,246 men with hypogonadism, testosterone did not increase major cardiovascular events compared with placebo (hazard ratio 0.96).

What patients paid for Reandron with and without public funding

Figures published by eldiario.es for the same product before and after it lost public funding. They do not necessarily reflect its current price.

SituationPrice paid by the patient
With SNS funding€4.29
Without funding, after returning to sale€128

The Seguridad Social, Spain's public health system, can pay for a large part of the cost of testosterone, but not automatically and not for every product. Two things are needed: a diagnosis of hypogonadism made by a doctor in the public system, and the prescribed medicine being included in funding from the Spanish National Health System (Sistema Nacional de Salud, SNS). If you are treated by a private doctor or a telemedicine service, you pay the full price of the medicine yourself.

Reandron shows how much the price can change. With public funding, patients paid €4.29. Once it was no longer funded, it went back on sale at €128. Below we explain what cover depends on, how to check it, and what is required before treatment, whether in the public or the private sector.

What decides whether the public system pays for testosterone

In Spain, funding is not granted to an active substance in general but to each commercial product: a specific brand, route (gel or injection) and dose. That is why two medicines containing the same molecule can have a different funding status, and the status of each can change over time because of pricing decisions, products being withdrawn from the market or supply problems.

For the public system to cover treatment, two conditions must be met:

  • A doctor in the public system has to prescribe it. Taking a private prescription to the pharmacy does not make it a funded one.
  • The prescribed product has to be included in the SNS pharmaceutical benefit at that time. If it is, you pay your share according to your co-payment level. If it isn't, you pay the full price.

We don't give the current status of each testosterone product (Testogel, Testim, Reandron and others) here, because we have not been able to confirm it from a complete official source. The reliable way to find out is to check the Ministry of Health's billing database (the Nomenclátor de facturación) or the AEMPS (Spanish Agency of Medicines and Medical Devices) CIMA search tool, or simply ask at your pharmacy, where staff can see straight away whether a medicine is funded.

The Reandron case: what happens when a medicine loses funding

Reandron 1000 is injectable testosterone undecanoate, one of the long-acting products. According to eldiario.es, the Ministry of Health imposed a 35% price cut on it when it set new reference prices. Bayer said it had offered a 26% reduction, which the Ministry did not accept. The company suspended sales and the medicine later returned to pharmacies, but without public funding: €128, compared with the €4.29 patients paid while it was funded.

The case shows two things. First, cover is not fixed: it depends on the Ministry and the manufacturer agreeing on a price. Second, when a product loses funding, patients can keep using it if they pay the full price, or switch with their doctor to another route that is funded. If you want to know how they differ in practice, we cover it in testosterone gel versus injectable undecanoate.

Supply matters too

Price isn't the only issue. Availability matters too. In 2016 the AEMPS published an information notice about supply problems with Testex Prolongatum 250 mg/2 mL, which is injectable testosterone cipionate. We don't know whether those problems are still ongoing or what its current funding status is. What it does show is that a funded medicine can be temporarily unavailable, and the doctor then has to find an alternative.

What has to happen before you are prescribed testosterone (public or private)

Who pays does not change the medical criteria. The Endocrine Society's 2018 guideline, an international reference, requires two things for a diagnosis of male hypogonadism: compatible symptoms and signs, and a clearly and repeatedly low total or free testosterone in blood tests. A single low result is not enough to start treatment.

The same guideline advises against routine testosterone testing of the whole population, and with good reason. In the European EMAS study of 3,369 men aged 40 to 79, only 2.1% met the criteria for late-onset hypogonadism: at least three sexual symptoms, total testosterone below 11 nmol/L (3.2 ng/mL) and free testosterone below 220 pmol/L (64 pg/mL). Feeling tired after 40 doesn't mean you have low testosterone. If you want to go over which symptoms really count, we explain it in low testosterone: the real symptoms and when to worry.

Contraindications also have to be ruled out before prescribing. According to the Endocrine Society, testosterone is not indicated in men who want to father children in the near future, or in men with breast or prostate cancer, a palpable prostate nodule, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke in the past six months, or thrombophilia. That is why specific blood tests are requested, which we detail in which blood tests you need before testosterone is prescribed.

What recent evidence says about safety

In the TRAVERSE trial of 5,246 men with hypogonadism, with an average age of 63 and either existing cardiovascular disease or high cardiovascular risk, testosterone did not increase major cardiovascular events compared with placebo (hazard ratio 0.96; 95% CI 0.78–1.17). A fracture analysis from the same trial did find more fractures with testosterone than with placebo: 91 versus 64. In February 2025, after reviewing TRAVERSE, the US Food and Drug Administration removed the warning about increased cardiovascular risk from the boxed warning and required all products to carry a warning about rises in blood pressure. That decision applies to the United States: we are not aware of the EMA or the AEMPS having changed their summaries of product characteristics. With a properly made diagnosis the balance of benefit and risk is reasonable, but follow-up is needed.

Public, private or telemedicine: what changes and what doesn't

In the public system, the usual first step is your GP (médico de atención primaria). They assess your symptoms and decide whether to order blood tests or refer you to a specialist. How this pathway is organised can vary between regional health services, so it is worth asking at your health centre.

In private care and telemedicine, the clinical criteria are the same: symptoms, repeated blood tests, ruling out contraindications and regular monitoring. The difference is who pays. Being treated outside the public system does not entitle you to have the medicine funded by the Seguridad Social: with a private prescription you pay the full price at the pharmacy. What is never an alternative is buying testosterone without a prescription from websites. We explain why in testosterone without a prescription and online sellers.

If you are comparing private or online services, these questions help separate a proper medical consultation from a shop: Are you seen by a registered doctor? Do they ask for at least two blood tests before deciding? Do they ask about your plans to have children and about your cardiovascular and prostate history? Do they offer regular check-ups with blood tests? Will they tell you clearly when treatment isn't right for you?

Key points and where to start

The Seguridad Social can fund testosterone, but only if it is prescribed within the public system and the product is funded at that time. Cover also changes: Reandron went from €4.29 to €128 when it lost funding. Wherever you are treated, a diagnosis requires symptoms and repeatedly low blood test results. If you prefer to go private, in Spain today you can get medical treatment after a prior assessment, with a registered doctor who prescribes only when it is indicated and then provides ongoing follow-up, as at AiON. The medicine is paid for separately, without public funding. You can:

Check in a few minutes whether male hormonal health treatment is right for you

Sources

The guide explains. The doctor decides.

Online assessment, prescription where appropriate and ongoing follow-up.

Frequently asked questions

How can I get prescribed testosterone treatment in Spain without going to a clinic in person?

There are telemedicine services where a registered doctor assesses you remotely and only prescribes if treatment is indicated. The criteria are the same as in a face-to-face consultation: compatible symptoms, blood tests showing repeatedly low testosterone, and ruling out contraindications. The prescription is private, so the medicine is not funded by the Seguridad Social.

What is the best online men's health clinic in Spain for low testosterone?

There is no official ranking. What you can check is whether a service meets some minimum quality standards: a registered doctor, at least two blood tests before any decision, questions about fertility and your cardiovascular and prostate history, and regular check-ups. Be wary of any service that sells you testosterone without blood tests or guarantees treatment before assessing you.

Where can I get testosterone therapy in Spain with proper medical follow-up?

In the public system, starting with your GP, or privately, either in person or by telemedicine. In every case, treatment needs regular monitoring with blood tests. The difference is that the medicine can only be funded through the public route.

How much does testosterone cost if the Seguridad Social doesn't cover it?

It depends on the product, and prices can change. The figure we have been able to verify is for Reandron, which was sold for €128 without funding, compared with the €4.29 patients paid while it was funded. To find out the current price of each product, the most reliable options are to ask at a pharmacy or check the Ministry of Health's Nomenclátor.

Can I get a testosterone blood test through the Seguridad Social?

Yes, if your doctor sees symptoms that justify it. The Endocrine Society advises against routine testing of the whole population, because hypogonadism is less common than people think: in the EMAS study, only 2.1% of men aged 40 to 79 met the criteria.

Also